Latest Articles
Impact of the Lipid–Inflammation Axis on Endometriosis Risk: A Multicenter Case–Control Study Using Mediation Analysis - Frontiers
Impact of the Lipid–Inflammation Axis on Endometriosis Risk: A Multicenter Case–Control Study Using Mediation Analysis Frontiers
Published: Oct. 28, 2025, 9:44 p.m.
Global, regional, and national burden and trends of endometriosis, 1990–2021: an analysis of the global burden of disease study 2021 and forecast to 2050 - BMC Women's Health
Global, regional, and national burden and trends of endometriosis, 1990–2021: an analysis of the global burden of disease study 2021 and forecast to 2050 BMC Women's Health
Published: Oct. 28, 2025, 1:02 p.m.
Enhanced analysis of endometriosis patients’ plasma using #Enzian annotation highlights potential biomarkers for early-stages of disease - Nature
Enhanced analysis of endometriosis patients’ plasma using #Enzian annotation highlights potential biomarkers for early-stages of disease Nature
Published: Oct. 28, 2025, 9:29 a.m.
Limerick woman (29) to undergo endometriosis surgery abroad after disease spread to heart - The Irish Times
Limerick woman (29) to undergo endometriosis surgery abroad after disease spread to heart The Irish Times
Published: Oct. 28, 2025, 6:02 a.m.
Limerick woman (29) to undergo endometriosis surgery in Greece after disease spread to heart - The Irish Times
Limerick woman (29) to undergo endometriosis surgery in Greece after disease spread to heart The Irish Times
Published: Oct. 28, 2025, 6:02 a.m.
Limerick woman (29) to have endometriosis surgery in Greece after disease spread to heart - The Irish Times
Limerick woman (29) to have endometriosis surgery in Greece after disease spread to heart The Irish Times
Published: Oct. 28, 2025, 6:02 a.m.
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - BioSpace
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer BioSpace
Published: Oct. 28, 2025, 5:03 a.m.
Genmab’s New Phase 3 Study: A Potential Game-Changer in Endometrial Cancer Treatment - TipRanks
Genmab’s New Phase 3 Study: A Potential Game-Changer in Endometrial Cancer Treatment TipRanks
Published: Oct. 27, 2025, 11:43 p.m.
BioNTech’s Promising Phase III Trial: A Potential Game-Changer in Endometrial Cancer Treatment - TipRanks
BioNTech’s Promising Phase III Trial: A Potential Game-Changer in Endometrial Cancer Treatment TipRanks
Published: Oct. 27, 2025, 10:53 p.m.
Aditxt Subsidiary Pearsanta Launches Clinical Study for Blood-Based Endometriosis Diagnostic - citybuzz -
Aditxt Subsidiary Pearsanta Launches Clinical Study for Blood-Based Endometriosis Diagnostic citybuzz -
Published: Oct. 27, 2025, 9:33 p.m.
Link copied to clipboard!